Results 181 to 190 of about 67,260 (268)
Comparison of Anomaly Detection Methods on Event-Based Vision Sensor Data in a High Noise Environment. [PDF]
Johnston W +6 more
europepmc +1 more source
A concept of winged space vehicle : HIMES vehicle.
openaire +1 more source
Senolytic Therapy as a Preventive Strategy for Spine Degeneration and Pain
Cellular senescence promotes inflammation, tissue degeneration, and chronic back pain. In sparc‐null mice, early oral administration of the senolytic agents o‐vanillin and RG‐7112 reduced senescent cell burden and pro‐inflammatory SASP signaling across intervertebral discs, endplates, vertebral bone, and spinal cord.
Saber Ghazizadeh +7 more
wiley +1 more source
Motorist's Disorientation Syndrome-A Narrative Review. [PDF]
Dumas G +5 more
europepmc +1 more source
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong +24 more
wiley +1 more source
Editorial: Reinforcement learning for real-world robot navigation. [PDF]
Wang P, Li X, Zhu M, Ma J.
europepmc +1 more source
ANKS1B in the nucleus accumbens plays a critical role in the transition from controlled to escalated cocaine intake. Mechanistically, ANKS1B interacts with CBP to epigenetically suppress FoxO3 through H3K27 acetylation. The ANKS1B‐CBP‐FoxO3 signaling cascade presents a novel theraputic target for the treatment of cocaine addiction.
Liping Yang +15 more
wiley +1 more source
DRLO-VANET: a deep reinforcement learning-based offloading framework for low-latency and energy-efficient task execution in VANETs. [PDF]
Neelima S, Sree SR, Ramakrishnaiah N.
europepmc +1 more source
MDM2 dependency in pediatric sarcomas is driven by a novel p53‐independent oncogenic cistrome alongside canonical p53 pathway suppression. This study introduces MDM2‐recruiting transcriptional and epigenetic machinery degraders (MDM2‐TEMADs) as a novel precision oncology modality.
Jiawei Zhou +21 more
wiley +1 more source

